4Monroe EW, Cohen SH, Kalbfleisch J. Combined H1 and H2 antihistamine therapy in chronic urticaria [J]. Arch Dermatol, 1981,117(7) :404 -407. 被引量：1
5Norn S, Permin H, Skov PS. H2 antihistamines (cimetidine) and allergic inflammatory reactions [J]. Allergy, 1980,35 ( 4 ): 357-361. 被引量：1
6Prakash A, Lamb HM. Mizolastine: a review of its use in allergic rhinitis and chronic idiopathic urticaria[J]. Biodmg, 1998, 10(1): 42-59. 被引量：1
7Sudo K, Nagai K, Yamada N. Inhibitory effects of mizolastine on 5-lipoxygenase[J]. Japan Pharmacol Ther, 1998, 26(Suppl): 155-157. 被引量：1
8Yamada N, Funayama K. Inhibitory effects of mizolastine on the release of mediators and antagonistic effects against mediators[J]. Japan Pharmacol Ther, 1998, 26(Suppl): 131-138. 被引量：1
9Kontou-Fili K. Clinical advantages of dual activity in urticaria[J]. Allergy, 2000,55(Suppl 64): 28-33. 被引量：1
10Delauehe-Cavallier MC, Chaufour S, Guerault E, et al. QT interval monitoring during clinical studies with mizolastine, a new H1 antihistamine[J]. C1in Exp Allergy, 1999, 29(Suppl 3): 206-211. 被引量：1
